Owlstone Medical

The company develops non-invasive Breath Biopsy technology to detect volatile organic compounds (VOCs) as biomarkers for early disease detection and precision medicine. Their products and services include breath collection stations, analytical platforms, and specialized tests for cancer, liver disease, and respiratory infections. They serve the clinical research and healthcare markets by providing tools for at-home multi-cancer early detection and monitoring chronic conditions like cystic fibrosis.